CAR Ts Kymriah, Yescarta get green light in EU

The European Commission approved Kymriah tisagenlecleucel from Novartis AG (NYSE:NVS; SIX:NOVN) and Yescarta axicabtagene ciloleucel from the Kite Pharma Inc. subsidiary of Gilead Sciences Inc. (NASDAQ:GILD), making them the

Read the full 295 word article

User Sign In